levodopa

Dopamine-Enhancing Therapies in Age-Related Macular Degeneration: Assessing Risk Reduction for Neovascular Conversion

This study evaluates the association of dopamine-enhancing drugs, especially levodopa, with lowered 3-year risk of progression from non-neovascular to neovascular AMD, offering promising insight into dopaminergic pathways in AMD management.